By Dean Seal

Bayer has tapped the head of its pharmaceuticals business for the Americas to take over all U.S. operations.

The German pharmaceutical and agricultural giant said Wednesday that Sebastian Guth will retain his leadership over the pharmaceuticals arm for the U.S. and Canada while ascending to the role of president for Bayer U.S.

Oversight of Bayer's pharmaceutical business in Latin America will shift to Heike Prinz, the head of commercial operations for the company's pharmaceutical operations in Europe, the Middle East and Africa.

The leadership shuffles follows the departure of former Bayer U.S. President Patrick Lockwood-Taylor, who left earlier this month to become CEO of Perrigo.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

June 21, 2023 10:38 ET (14:38 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Bayer Aktiengesellschaft (PK) Charts.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Bayer Aktiengesellschaft (PK) Charts.